Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

Ozempic, a GLP-1 drug, has been a game-changer for many, including the author, allowing them to enjoy their pregnancy without ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...